homovanillic acid has been researched along with Cognition Disorders in 23 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)." | 7.72 | 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004) |
| " In the present study, we examined the association between blood levels of 3-methoxy-4-hydroxyphenylglycol (MHPG), homovanillic acid (HVA), or brain-derived neurotrophic factor (BDNF) and scores on the Wisconsin Card Sorting Test (WCST) in patients with early-stage schizophrenia." | 3.75 | Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia. ( Goto, N; Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Kakeda, S; Korogi, Y; Moriya, J; Nakamura, J; Ueda, N; Umene-Nakano, W; Yoshimura, R, 2009) |
| "In this study we investigated the cerebrospinal fluid (CSF) concentrations of 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in Alzheimer (AD) patients (n=75), patients with mild cognitive impairment (MCI, n=9) and patients with depression (n=7)." | 3.72 | 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. ( Ganzer, S; Müller-Thomsen, T; Stuerenburg, HJ, 2004) |
| "Lewy body disorders, including Parkinson's disease (PD), Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), are characterized by profound central and peripheral monoaminergic dysfunction." | 1.48 | Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease. ( Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y, 2018) |
| "Schizophrenia is associated with multiple cognitive deficits which in turn may be related to abnormal dopamine (DA) function." | 1.29 | Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. ( Apter, S; Davidson, M; Davis, KL; Harvey, PD; Kahn, RS; Keefe, RS; Mohs, RC; Neale, JM, 1994) |
| "In patients with Parkinson's disease the levels of somatostatin-like immunoreactivity were lower than in controls (P less than ." | 1.28 | Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy. ( Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (30.43) | 18.7374 |
| 1990's | 6 (26.09) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Zee, S | 1 |
| Vermeiren, Y | 1 |
| Fransen, E | 1 |
| Van Dam, D | 1 |
| Aerts, T | 1 |
| Gerritsen, MJ | 1 |
| Spikman, JM | 1 |
| van Laar, T | 1 |
| De Deyn, PP | 1 |
| Evers, LJ | 1 |
| Curfs, LM | 1 |
| Bakker, JA | 1 |
| Boot, E | 1 |
| da Silva Alves, F | 1 |
| Abeling, N | 1 |
| Bierau, J | 1 |
| Drukker, M | 1 |
| van Amelsvoort, TA | 1 |
| Aguiar, AS | 1 |
| Lopes, SC | 1 |
| Tristão, FS | 1 |
| Rial, D | 1 |
| de Oliveira, G | 1 |
| da Cunha, C | 1 |
| Raisman-Vozari, R | 1 |
| Prediger, RD | 1 |
| Goto, N | 1 |
| Yoshimura, R | 1 |
| Kakeda, S | 1 |
| Moriya, J | 1 |
| Hayashi, K | 1 |
| Ikenouchi-Sugita, A | 1 |
| Umene-Nakano, W | 1 |
| Hori, H | 1 |
| Ueda, N | 1 |
| Korogi, Y | 1 |
| Nakamura, J | 1 |
| Kumar, AM | 1 |
| Ownby, RL | 1 |
| Waldrop-Valverde, D | 1 |
| Fernandez, B | 1 |
| Kumar, M | 1 |
| Pomara, N | 1 |
| Willoughby, LM | 1 |
| Hashim, A | 1 |
| Sershen, H | 1 |
| Sidtis, JJ | 1 |
| Wesnes, K | 1 |
| Greenblatt, DJ | 1 |
| Lajtha, A | 1 |
| Stuerenburg, HJ | 1 |
| Ganzer, S | 1 |
| Müller-Thomsen, T | 1 |
| Castner, SA | 1 |
| Vosler, PS | 1 |
| Goldman-Rakic, PS | 1 |
| Leckman, JF | 1 |
| Cohen, DJ | 1 |
| Shaywitz, BA | 1 |
| Caparulo, BK | 1 |
| Heninger, GR | 1 |
| Bowers, MB | 1 |
| McEntee, WJ | 1 |
| Mair, RG | 1 |
| Langlais, PJ | 1 |
| Mann, JJ | 1 |
| Stanley, M | 1 |
| Neophytides, A | 1 |
| de Leon, MJ | 1 |
| Ferris, SH | 1 |
| Gershon, S | 2 |
| Kahn, RS | 1 |
| Harvey, PD | 1 |
| Davidson, M | 1 |
| Keefe, RS | 1 |
| Apter, S | 1 |
| Neale, JM | 1 |
| Mohs, RC | 1 |
| Davis, KL | 1 |
| Gilbertson, MW | 1 |
| Yao, JK | 1 |
| van Kammen, DP | 1 |
| Sheline, YI | 1 |
| Miller, K | 1 |
| Bardgett, ME | 1 |
| Csernansky, JG | 1 |
| Poirier, MF | 1 |
| Heim, C | 1 |
| Zhang, J | 1 |
| Lan, J | 1 |
| Sieklucka, M | 1 |
| Kurz, T | 1 |
| Riederer, P | 1 |
| Gerlach, M | 1 |
| Sontag, KH | 1 |
| del Ser, T | 1 |
| Masson, H | 1 |
| Popescu, I | 1 |
| Strubel, D | 1 |
| Cramer, H | 1 |
| Kuntzmann, F | 1 |
| Hildebrand, J | 1 |
| Bourgeois, F | 1 |
| Buyse, M | 1 |
| Przedborski, S | 1 |
| Goldman, S | 1 |
| Mayeux, R | 1 |
| Stern, Y | 1 |
| Sano, M | 1 |
| Cote, L | 1 |
| Williams, JB | 1 |
| Palmer, AM | 1 |
| Francis, PT | 1 |
| Bowen, DM | 1 |
| Benton, JS | 1 |
| Neary, D | 1 |
| Mann, DM | 1 |
| Snowden, JS | 1 |
| Portin, R | 1 |
| Rinne, UK | 1 |
| Angrist, B | 1 |
| Sathananthan, G | 1 |
| Wilk, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00004325] | 200 participants | Observational | 1988-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for homovanillic acid and Cognition Disorders
| Article | Year |
|---|---|
[Biological approaches to acute psychoses].
Topics: Acute Disease; Antipsychotic Agents; Brain; Cognition Disorders; Homovanillic Acid; Humans; Magnetic | 1999 |
[Clinical manifestation of frontotemporal dementia].
Topics: Alzheimer Disease; Atrophy; Cognition Disorders; Diagnosis, Differential; Frontal Lobe; Homovanillic | 2000 |
2 trials available for homovanillic acid and Cognition Disorders
| Article | Year |
|---|---|
Effects of acute lorazepam administration on aminergic activity in normal elderly subjects: relationship to performance effects and apolipoprotein genotype.
Topics: Aged; Analysis of Variance; Anti-Anxiety Agents; Apolipoprotein E4; Apolipoproteins; Apolipoproteins | 2004 |
Memory and plasma HVA changes in schizophrenia: are they episode markers?
Topics: Adult; Biomarkers; Cognition Disorders; Double-Blind Method; Haloperidol; Homovanillic Acid; Humans; | 1994 |
19 other studies available for homovanillic acid and Cognition Disorders
| Article | Year |
|---|---|
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differ | 2018 |
Serotonergic, noradrenergic and dopaminergic markers are related to cognitive function in adults with 22q11 deletion syndrome.
Topics: 22q11 Deletion Syndrome; Adult; Biomarkers; Case-Control Studies; Cognition Disorders; Dopamine; Fem | 2014 |
Exercise Improves Cognitive Impairment and Dopamine Metabolism in MPTP-Treated Mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catale | 2016 |
Associations between plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) and negative symptoms or cognitive impairments in early-stage schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cognition Disorders; Fem | 2009 |
Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Brain; Cognition Disorders; Dopamine; Female; HI | 2011 |
5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Depression; Dopamine; Female; Homovanillic Acid; Human | 2004 |
Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Centra | 2005 |
CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
Topics: Adolescent; Adult; Age Factors; Aged; Autistic Disorder; Bipolar Disorder; Child; Child, Preschool; | 1980 |
Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders.
Topics: Alcohol Amnestic Disorder; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacet | 1984 |
Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
Topics: Aged; Alzheimer Disease; Blood Platelets; Cognition Disorders; Dementia; Glycols; Homovanillic Acid; | 1981 |
Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.
Topics: Adult; Cerebral Cortex; Cognition Disorders; Discrimination Learning; Dopamine; Homovanillic Acid; H | 1994 |
Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Female; Homovanillic Acid; Humans; | 1998 |
Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aspartic Acid; Carotid Stenosis; Cognition Disorders; Corpu | 2000 |
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; | 1990 |
Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.
Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Cognition Disorders; Female; G | 1990 |
Clinical and biochemical correlates of bradyphrenia in Parkinson's disease.
Topics: Aged; Alzheimer Disease; Arousal; Attention; Biogenic Amines; Cognition Disorders; Homovanillic Acid | 1987 |
Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.
Topics: Adult; Aged; Alzheimer Disease; Catecholamines; Cerebral Cortex; Choline O-Acetyltransferase; Cognit | 1987 |
Predictive factors for cognitive deterioration and dementia in Parkinson's disease.
Topics: Cognition Disorders; Dementia; Electroencephalography; Homovanillic Acid; Humans; Levodopa; Parkinso | 1987 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depressio | 1974 |